Integrated Care for Migraine and Chronic Tension-type Headaches
Integrated Care for Migraine and Chronic Tension-type Headaches
Chronic headache is among the most common neurological disorders with major physical,
 psychological, social and economic impact. The aim of this prospective observational study
 isto investigate the effects of an interdisciplinary multimodal integrated care program in
 patients with chronic migraine and/or tension-type headache.

 158 patients with chronic migraine or tensions-type headache at least five days per month for
 at least 6 months and current intake of triptans (migraine) or analgesic drugs (tension-type
 headache) are eligible. Patients undergo inpatient, outpatient and/or semi-stationary
 treatment including conventional headache diagnostics and therapy as well as traditional
 Chinese medicine, European naturopathy, and mind-body-medicine approaches. Headache frequency
 is defined as the primary outcome; secondary outcomes include pain (visual analog scale, Pain
 Perception Scale), triptans and analgesics use (headache diary), health-related quality of
 life (SF-36), function (Headache Disability Inventory, Patient-specific Functional Scale),
 depression and anxiety (Hospital Anxiety and Depression Scale), and pain self-efficacy (Pain
 Self-Efficacy Questionnaire). Outcomes are assessed at treatment start, treatment end and 6
 months after treatment end.
Chronic headache is among the most common neurological disorders with major physical,
 psychological, social and economic impact. The aim of this prospective observational study
 isto investigate the effects of an interdisciplinary multimodal integrated care program in
 patients with chronic migraine and/or tension-type headache.

 158 patients with chronic migraine or tensions-type headache at least five days per month for
 at least 6 months and current intake of triptans (migraine) or analgesic drugs (tension-type
 headache) are eligible. Patients undergo inpatient, outpatient and/or semi-stationary
 treatment including conventional headache diagnostics and therapy as well as traditional
 Chinese medicine, European naturopathy, and mind-body-medicine approaches. Headache frequency
 is defined as the primary outcome; secondary outcomes include pain (visual analog scale, Pain
 Perception Scale), triptans and analgesics use (headache diary), health-related quality of
 life (SF-36), function (Headache Disability Inventory, Patient-specific Functional Scale),
 depression and anxiety (Hospital Anxiety and Depression Scale), and pain self-efficacy (Pain
 Self-Efficacy Questionnaire). Outcomes are assessed at treatment start, treatment end and 6
 months after treatment end.
Inclusion Criteria:

 headache at least five days per month for at least 6 months current intake of a) at least
 10 triptans per month or b) analgesic drugs that can themselves elicit headache

 Exclusion Criteria: None.